Citable filing context
EPAM's research view summarizes recent SEC filing context, starting with earnings from Aug 6, 2026.
| Filed | Item | Context |
|---|---|---|
| Aug 6, 2026 | earnings | EPAM reported Q2 2026 revenue of $1.415 billion, a 4.5% year-over-year increase. |
| May 26, 2026 | other | EPAM stockholders approved incentive plan and charter amendments and elected Class II directors at the 2026 Annual Meeting. |
| May 7, 2026 | earnings | EPAM reported Q1 2026 revenues of $1.400 billion, up 7.6% year-over-year, and GAAP diluted EPS of $1.52. |
| Aug 6, 2026 | Guidance: gaap_diluted_eps | 2.33 to 2.41 |
| Aug 6, 2026 | Guidance: gaap_diluted_eps | 8.22 to 8.38 |
| Aug 6, 2026 | Guidance: gaap_operating_margin | 10.50 to 11.00 |
| Aug 6, 2026 | mda_quarterly | EPAM reported revenue of $2.815 billion for the first half of 2026, a 6.0% increase year-over-year, driven by improved demand and foreign exchange tailwinds. Operating income margin expanded to 9.6% from 8.5%, reflecting successful cost optimization initiatives and reduced compensation expenses as a percentage of revenue. Diluted earnings per share rose to $3.49, bolstered by operational gains and share repurchases, including an Accelerated Share Repurchase program. Geographically, the Americas remains the largest market, though growth was modest at 1.5% for the half-year, with strength in Financial Services offset by declines in Software & Hi-Tech. The Europe segment outperformed, growing 12.5% with significant gains in Life Sciences & Healthcare and Software & Hi-Tech. The ongoing war in Ukraine remains a material risk; while the company maintains significant delivery capacity in the region, it continues to incur elevated expenses related to business continuity and a $100 million humanitarian commitment. Liquidity remains stable with $789.4 million in cash and equivalents, though operating cash flow was pressured by variable compensation payments and increased days sales outstanding. Management expects current resources to sufficiently fund operations and strategic investments over the next twelve months despite ongoing geopolitical and macroeconomic uncertainties. |
| May 7, 2026 | mda_quarterly | EPAM reported first-quarter 2026 revenues of $1.400 billion, a 7.6% increase year-over-year, driven by improving demand and foreign exchange fluctuations. Operating income as a percentage of revenue rose to 8.3%, and diluted EPS increased to $1.52. The company is scaling AI-enabled transformation through platforms like EPAM AI/RUN™ and DIALX Lab™. Geographically, the United States remains the largest market, while EMEA revenues grew to $576 million. In the Americas, Financial Services grew 10.8%, though Software & Hi-Tech declined 2.1%. Conversely, Europe saw significant growth in Software & Hi-Tech (+43.2%) and Life Sciences & Healthcare (+34.9%). The war in Ukraine continues to pose material risks and operational costs, with $7.1 million remaining of a $100 million humanitarian commitment. Liquidity remains robust with $1.037 billion in cash and equivalents. Capital allocation focused heavily on shareholder returns, with $324 million spent on share repurchases, including a $300 million Accelerated Share Repurchase (ASR) partially funded by a $140 million draw on a revolving credit facility. Cost pressures persist due to salary increases and promotions from the prior annual compensation cycle, though these were partially offset by cost optimization initiatives. |
Source: SEC EDGAR filing text and events; period Aug 6, 2026; filed Aug 6, 2026.
EPAM company research is available with Aerarium Pro (CAD $10/mo). The five showcase tickers (TSLA, NVDA, AAPL, AMZN, PLTR) and the macro dashboard stay free. Already a subscriber? Sign in to pick up where you left off.